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Abstract
Background: Mastitis is the most prevalent disease in dairy sheep with major economic, hygienic and welfare
implications. The disease persists in all dairy sheep production systems despite the implementation of improved
management practises. Selective breeding for enhanced mastitis resistance may provide the means to further
control the disease. In the present study, we investigated the genetic architecture of four mastitis traits in dairy
sheep. Individual animal records for clinical mastitis occurrence and three mastitis indicator traits (milk somatic
cell count, total viable bacterial count in milk and the California mastitis test) were collected monthly throughout
lactation for 609 ewes of the Greek Chios breed. All animals were genotyped with a custom-made 960-single
nucleotide polymorphism (SNP) DNA array based on markers located in quantitative trait loci (QTL) regions for
mastitis resistance previously detected in three other distinct dairy sheep populations.
Results: Heritable variation and strong positive genetic correlations were estimated for clinical mastitis occurrence and
the three mastitis indicator traits. SNP markers significantly associated with these mastitis traits were confirmed
on chromosomes 2, 3, 5, 16 and 19. We identified pathways, molecular interaction networks and functional gene
clusters for mastitis resistance. Candidate genes within the detected regions were identified based upon analysis
of an ovine transcriptional atlas and transcriptome data derived from milk somatic cells. Relevant candidate genes
implicated in innate immunity included SOCS2, CTLA4, C6, C7, C9, PTGER4, DAB2, CARD6, OSMR, PLXNC1, IDH1, ICOS, FYB,
and LYFR.
Conclusions: The results confirmed the presence of animal genetic variability in mastitis resistance and identified genomic
regions associated with specific mastitis traits in the Chios sheep. The conserved genetic architecture of mastitis resistance
between distinct dairy sheep breeds suggests that across-breed selection programmes would be feasible.
Keywords: Genomic association, Sheep transcriptomic atlas, Milk transcriptome, Transcription factor binding sites, Mastitis,
Somatic cell count, Total viable bacterial count, California mastitis test, Chios sheep, Dairy sheep
Background
Mastitis is an inflammation of the mammary gland usually
caused by pathogens, mainly bacteria, developed in the
gland cistern after penetration through the teat canal. It is
the most prevalent and costly disease in the dairy industry
due to reduced and discarded milk, early involuntary
culling, veterinary service and labour costs [1, 2]. There is
also the possibility for the spread of a zoonotic disease as
well as the development of microbial resistance to
antibiotics [1–3]. Mastitis compromises animal welfare
causing pain, anxiety, restlessness and changes in feeding
behaviour [4]. The issue of mastitis is a central element in
the design and implementation of management schemes
in dairy sheep farms. The notion is that for every case of
confirmed clinical mastitis there are at least 40 other
animals in the flock with subclinical mastitis. Reviews of
management practices and practical approaches to control
sheep mastitis have been published [5, 6].
The susceptibility of dairy animals to udder infection
is heritable [2, 7–9] but the current knowledge of the
complex physiological and cellular events that occur in
the mammary gland in response to pathogens is limited.
In cattle, the common mastitis pathogens, Escherichia coli
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(E. coli) and Staphylococcus aureus (S. aureus), activate the
mammary immune system in different ways, influencing
disease severity and chronicity [10]. The recruitment of
leukocytes (neutrophils) in the udder in response to infec-
tion is measured as the milk somatic cell count (SCC) [11].
Breeding programmes based on animal pedigrees and SCC
records (as a correlated trait for mastitis) have been imple-
mented in dairy cattle worldwide [12] as well as the French
Lacaune dairy sheep [13, 14]. Marker assisted selection or
genomic selection based on genotyping of single nucleotide
polymorphism (SNP) markers could enhance and expedite
the efforts for genetic improvement.
Quantitative trait loci (QTLs) and SNPs associated
with SCC have been previously identified based on link-
age and linkage disequilibrium analyses of three distinct
dairy sheep breeds (French Lacaune, Spanish Churra
and Italian Sarda [15–19]). Several QTLs were common
(i.e. located within 2 Mb regions) to two or more breeds
in these studies. A custom-made 960-SNP DNA array
for ovine mastitis resistance containing markers on six
chromosomes (2, 3, 5, 12, 16 and 19) was then developed.
The array was based on the common QTLs among breeds
and some additional well-defined (i.e. confidence interval
less than 0.5 Mb) QTL regions with large effects, as well as
further genotyping with the Illumina OvineSNP800 Bead
chip and re-sequencing of selected QTL regions
(Additional file 1: Table S1) within an FP7 European
funded project (http://cordis.europa.eu/result/rcn/163
471_en.html). For the design of the custom-made
array, SNPs were selected from both the 50 K and
the 800 K SNP DNA arrays, as well as the available
re-sequencing data; the array had an average density
of 1 SNP every 23 Kb. The present study builds on
results from previous studies on Lacaune, Churra and
Sarda sheep [15–19] in order to dissect the genomic archi-
tecture of mastitis resistance in an independent sheep
population, the Greek Chios breed. Genotyping was per-
formed with the aforementioned mastitis-specific custom-
made DNA array. We conducted variance component
analyses to estimate genetic parameters and genomic asso-
ciation studies to identify genomic regions controlling
mastitis. We also performed pathway analysis and exam-
ined gene expression and transcription factor binding site
data to identify candidate genes within the relevant
genomic regions.
Results
Principal component analysis
French Lacaune, Spanish Churra, Italian Sarda and Greek
Chios were among the sheep breeds analysed within the
framework of the sheep HapMap project [20]. Principal
component analysis (PCA) was performed to examine the
relatedness among these dairy breeds using genotypes
obtained with the Illumina OvineSNP50 Beadchip within
the HapMap project. According to the results, the four
dairy breeds are genetically distinct with the first and
second PCA clusters explaining 14.4% and 9.9% of the
variance, respectively (Additional file 2: Figure S1). Chios
is equally distant from any one of the other three breeds,
with an average pairwise genetic distance (Dst) of 0.33,
confirming its independent population status for the
purposes of the present study.
Descriptive statistics of phenotypes
Descriptive statistics for SCC, California mastitis test
(CMT) and total viable bacterial count in milk (TVC)
are listed in Additional file 3: Table S2. The average
frequency of clinical mastitis occurrence (CM) was 5.1%
in our studied population. Gram positive (58% Coagulase
negative Staphylococci, 22% S. aureus and 7.7% Streptococcus
spp) bacteria were mainly responsible for CM. Nevertheless,
Gram negative bacteria (9.3% Pasteurella spp. and 3%
Proteus) were also isolated from the milk samples.
Smoothed curves illustrating progression for each trait
throughout lactation, after adjusting for all relevant
sources of systematic variation, are shown in Fig. 1. These
curves were based on second order polynomial functions
of time (week of lactation) fitted in mixed model analyses
of the studied traits. Higher order polynomials did not
improve the model fit as attested to by the Wald statistic.
As expected, values of SCC and CMT generally increased
as lactation progressed [21]. TVC and CM values first
showed a relative decrease until week 11 of lactation and
then started gradually increasing.
Genetic parameters
Estimates of heritability and repeatability of the studied
traits (Table 1) based on monthly records were derived
for the entire lactation as well as different stages of
lactation defined as early (weeks of lactation 1–7), mid
(weeks 8–17) and late (weeks 18–23). Because of the
binary nature of CM, only overall lactation heritability
and repeatability estimates were possible to derive for
this trait. Low to moderate heritabilities (0.09–0.18) were
estimated for all the mastitis traits; higher heritability
estimates were observed in all cases toward the end of
lactation. Moreover, the genetic correlations between the
different lactation stages were positive for all studied
traits (Additional file 4: Table S3). However, the genetic
correlations between early and late lactation were low to
moderate (0.26–0.56) suggesting that somewhat distinct
genetic mechanisms may control mastitis resistance at
different lactation stages. The three mastitis indicator
traits (SCC, TVC and CMT) were correlated, both
phenotypically and genetically, with each other and with
CM, suggesting that any of the three indirect mastitis
traits would be a useful predictor of CM. The genetic
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and phenotypic correlation estimates between traits are
presented in Table 2.
Genomic association studies
Genomic association studies were conducted separately
for early, mid, late and overall lactation for each trait.
Multidimensional scaling analysis (MDS) revealed no
substructure in the Chios population. In general, similar
genomic associations were detected for CM and the
three mastitis indicator traits but distinct associations
were observed in the different lactation stages. SNPs
significantly associated with the studied mastitis traits
are shown in Table 3. Five (four at genome-wide and
one at suggestive genome-wide significant level) of the
seven QTLs previously identified in other dairy breeds were
verified in the independent Chios population (Additional
file 1: Table S1). Q-Q plots supported the genomic analyses
results. Manhattan plots displaying these association results
are shown in Fig. 2; the corresponding Q-Q plots are
shown in Additional file 5: Figure S2.
All significant SNP markers that were identified in the
genomic association study had also a significant effect
Fig. 1 Smoothed fixed curves of the mastitis traits studied in Chios sheep by week of lactation. Curves for milk somatic cell count (SCC), California
mastitis test (CMT), total viable bacterial count in milk (TVC) and clinical mastitis occurrence (CM) are presented
Table 1 Heritability (h2) and repeatability (r) estimates for four mastitis traits studied in Chios sheep, by stage of lactation
Trait Parameter Early lactation
(weeks 1–7)
Mid lactation
(weeks 8–17)
Late lactation
(weeks 18–23)
Overall lactation
(weeks 1–23)
SCC h2 0.10 (0.05) 0.09 (0.05) 0.18 (0.05) 0.11 (0.05)
r 0.55 (0.03) 0.54 (0.02) 0.66 (0.02) 0.58 (0.02)
CMT h2 0.12 (0.06) 0.10 (0.05) 0.17 (0.06) 0.12 (0.06)
r 0.60 (0.03) 0.59 (0.02) 0.68 (0.02) 0.62 (0.02)
TVC h2 0.09 (0.05) 0.08 (0.04) 0.15 (0.05) 0.09 (0.05)
r 0.28 (0.04) 0.27 (0.03) 0.34 (0.04) 0.33 (0.04)
CM h2 NA NA NA 0.18 (0.10)
r NA NA NA 0.35 (0.06)
SCC log-transformed milk somatic cell count; CMT California mastitis test; TVC log-transformed total viable bacterial count in milk; CM clinical mastitis occurrence
(0/1, analysed with a logit function); NA non-applicable; standard errors in parentheses
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on the corresponding mastitis traits in the ensuing mixed
model analyses based on the pedigree genetic relationship
matrix among animals. The additive and dominance genetic
effects, and the proportion of the total genetic and
phenotypic variance explained by each of these SNPs,
are summarised in Table 3. Individual significant SNP
markers explained up to 27%, 39%, 33% and 39% of the
genetic variance of CMT, SCC, TVC and CM, respectively.
The significant markers corresponding to the same QTL
were in linkage disequilibrium (LD as r2 = 0.20–0.97), im-
plying that they likely correspond to the same causative
variation (Additional file 6: Table S4). Only small LD blocks
(less than 200 kb length) were visualised with Haploview,
probably due to a high number of recombination events
having taken place in the outbred Chios population
(Additional file 7: Figure S3). The significant markers
were located in close proximity to each other, with most
of them being inside neighbouring small LD blocks, and
spanned the previously identified QTL regions in Lacaune,
Churra and Sarda (Additional file 7: Figure S3).
Annotation of SNP markers and QTL candidate regions
A relatively small number of genes (53 protein-coding
and 26 microRNAs) were identified in the candidate re-
gions for mastitis resistance (Additional file 8: Table S5).
All significant SNP markers, with two exceptions, were
located in intergenic or intronic regions. The exceptions
were two SNPs associated significantly with TVC (oar3_
OAR2_209,240,636) and SCC (Oar3_Oar2_208,650,955)
in late lactation, which correspond to a missense variant
in the exonic region of an enzyme of the citric acid cycle
(isocitrate dehydrogenase 1, IDH1) and to a non-coding
lincRNA variant, respectively. Annotations of all signifi-
cant SNP markers for CM, SCC, CMT and TVC, are
presented in Additional file 9: Table S6.
Pathway and functional clustering analysis
Based upon the significant heritability estimates and the
large amount of genetic variance accounted for by the
identified SNPs, we reasoned that the corresponding QTL
regions would contain genes contributing to a common
pathway associated with mastitis resistance. We therefore
identified the sets of annotated genes lying within QTL in-
tervals and sought evidence of gene set enrichment. These
genes were enriched for pathways involved in inflammatory
and immune responses, both innate and adaptive (Fig. 3a).
Moreover, two networks of molecular interactions related
to immunological diseases were constructed using the list
of genes in the candidate regions (Fig. 3b). We further ex-
tracted the gene ontology (GO) terms for each of the genes
and performed functional annotation clustering analysis.
These genes were organised into 18 clusters, each given an
enrichment score (ES) (Additional file 10: Table S7). The
first (ES = 2.33) and the third (ES = 1.53) clusters were
related to the regulation of apoptosis, and to innate and
adaptive immune responses involving the same immune
genes identified with the pathway and network analyses
(C6, C8, C9, CD28, OSMR, SOCS2, CREB1, ICOS, CTLA4,
NRP2, PRPKAA1, DAB2, LIFR, PTGER4, UBE2N, IDH1).
Gene expression analysis
Genes that contribute to mastitis resistance are likely to
be expressed in milk somatic cells, in other immune
cells, and/or in the mammary gland, and much of the
genetic variation is likely to affect their transcriptional
regulation. In humans, more than 80% of genes that are
induced in stimulated monocytes have shown evidence
of heritable variation in their level of expression (eQTL)
[22]. To assess the expression profiles of genes located
in the candidate regions for mastitis resistance, we ob-
tained data from an ovine transcriptional atlas currently
under development at the Roslin Institute, which is based
upon the large-scale mRNA sequencing of multiple tissues
and cell lines [23]; this development builds upon similar
initiatives in other species [24, 25]. We also used data
from an RNA-seq characterisation of the milk transcrip-
tome of two Spanish dairy sheep breeds, Churra and
Assaf, where milk somatic cells had been sampled at 10,
50, 120 and 150 days after lambing [26, 27]. A previous
study identified genes involved in response to bacterial
lipopolysaccharide (LPS), the major component of the
outer membrane of Gram-negative bacteria, in a mouse
mammary gland model of mastitis [28]. A similar model of
mastitis has also been implemented in dairy cattle [29–31].
We reasoned that genes involved in mastitis susceptibility
would likely be constitutively expressed in the mammary
gland and immune tissues and/or differentially expressed in
sheep bone marrow-derived macrophages (BMDMs) in
response to LPS treatment. Both sources have been exten-
sively analysed in the sheep atlas. In addition, we reasoned
that these genes would be differentially expressed in sheep
with high, intermediate and low SCC and/or their expres-
sion levels would correlate with SCC [32]. The sheep used
in the milk transcriptomic study had also been phenotyped
for SCC and milk yield [26, 27].
Table 2 Estimates of genetic (above diagonal) and phenotypic
(below diagonal) correlations between the mastitis traits studied
in Chios sheep (overall lactation)
SCC CMT TVC CM
SCC 0.77 (0.11) 0.56 (0.12) 0.35 (0.16)
CMT 0.85 (0.02) 0.21 (0.12) 0.36 (0.17)
TVC 0.64 (0.02) 0.65 (0.02) 0.35 (0.17)
CM 0.35 (0.03) 0.39 (0.03) 0.33 (0.03)
SCC log-transformed milk somatic cell counts; CMT California mastitis test; TVC
log-transformed total viable bacterial count in milk; CM clinical mastitis occurrence
(0/1); standard errors in parentheses
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Table 3 List of SNPs associated with clinical mastitis occurrence and three mastitis indicator traits in Chios sheep
Trait Lactation stage SNP aChr(position) GAS a d PVA PVP p q
P-value (P-value) (P-value)
SCC early (weeks 1–7) oar3_OAR19_27,830,713 19(27830713) 5.54E-04 −0.39(0.00) −0.09(0.42) 0.36 0.04 0.62 0.38
oar3_OAR19_27,397,476 19(27397476) 7.74E-04 −0.41(0.03) 0.32(0.15) 0.38 0.04 0.34 0.66
OAR19_29193780 19(27558690) 8.00E-04 0.46(0.00) 0.30(0.04) 0.4 0.04 0.75 0.25
OAR19_29776311 19(28134366) 1.28E-03 0.33(0.09) 0.09(0.26) 0.12 0.01 0.87 0.13
late (weeks 18–23) oar3_OAR2_208,650,955 2(208650955) 2.31E-05 −0.24(0.07) −0.52(0.00) 0.19 0.01 0.71 0.29
oar3_OAR2_206,805,418 2(206805418) 8.25E-05 −0.27(0.00) 0.45(0.13) 0.07 0 0.99 0.01
OAR2_219641896 2(207420807) 1.65E-04 −0.14(0.46) 0.22(0.25) 0.01 0 0.83 0.17
OAR2_216496832 2(204569747) 1.89E-04 −0.22(0.04) 0.01(0.91) 0.11 0.01 0.38 0.62
oar3_OAR2_208,711,940 2(208711940) 6.73E-04 0.11(0.41) −0.68(0.00) 0.18 0 0.19 0.81
oar3_OAR2_207,141,059 2(207141059) 9.52E-04 −0.14(0.00) −0.84(0.00) 0.14 0 0.96 0.04
oar3_OAR2_205,201,880 2(205201880) 1.44E-03 −0.28(0.01) 0.03(0.79) 0.08 0.01 0.64 0.36
oar3_OAR2_204,683,757 2(204683757) 1.51E-03 −0.20(0.04) 0.09(0.42) 0.04 0.01 0.49 0.51
oar3_OAR19_27,100,147 19(27100147) 2.75E-05 0.52(0.02) 0.63(0.00) 0.39 0.03 0.85 0.15
overall (weeks 1–23) OAR16_38842323 16(35633299) 1.69E-03 −0.18(0.01) 0.12(0.13) 0.04 0 0.8 0.2
oar3_OAR19_27,830,713 19(27830713) 1.45E-03 −0.21(0.01) 0.15(0.16) 0.09 0.01 0.62 0.38
CMT early (weeks 1–7) oar3_OAR19_27,397,476 19(27397476) 3.67E-04 −0.36(0.00) 0.07(0.50) 0.28 0.03 0.34 0.66
oar3_OAR19_27,100,147 19(27100147) 3.93E-04 0.57(0.06) 0.33(0.31) 0.39 0.05 0.85 0.15
OAR19_29776311 19(28134366) 4.78E-04 0.37(0.05) 0.10(0.60) 0.15 0.02 0.87 0.13
OAR19_29193780 19(27558690) 9.22E-04 0.42(0.00) 0.21(0.12) 0.31 0.04 0.75 0.25
oar3_OAR19_27,723,161 19(27723161) 1.18E-03 0.34(0.04) 0.11(0.54) 0.14 0.02 0.85 0.15
mid (weeks 8–17) oar3_OAR19_27,830,713 19(27830713) 4.31E-04 −0.20(0.01) 0.09(0.35) 0.11 0.01 0.62 0.38
OAR19_27896777 19(26442150) 6.20E-04 0.61(0.01) 0.15(0.56) 0.19 0.04 0.91 0.09
oar3_OAR19_27,264,253 19(27264253) 9.35E-04 0.20(0.01) −0.02(0.79) 0.11 0.01 0.59 0.41
late (weeks 18–23) oar3_OAR2_206,805,418 2(206805418) 9.71E-04 −0.19(0.00) 0.29(0.28) 0.03 0 0.99 0.01
oar3_OAR3_130,101,204 3(130101204) 1.18E-03 0.12(0.00) 0.14(0.15) 0.01 0 0.9 0.1
OAR3_130,096,528.3SR 3(130096528) 1.32E-03 0.93(0.17) 0.98(0.16) 0.43 0.07 0.9 0.1
oar3_OAR16_35,319,166 16(35319166) 4.60E-04 −0.22(0.12) 0.26(0.16) 0.04 0.01 0.81 0.19
OAR16_37125504 16(34187287) 1.21E-03 −0.69(0.02) −0.38(0.23) 0.24 0.04 0.89 0.11
oar3_OAR19_27,100,147 19(27100147) 1.79E-05 0.63(0.00) 0.79(0.00) 0.27 0.05 0.85 0.15
oar3_OAR19_26,711,220 19(26711220) 7.13E-04 0.08(0.00) −0.03(0.74) 0.01 0 0.93 0.07
oar3_OAR19_27,830,713 19(27830713) 1.16E-03 −0.20(0.01) 0.09(0.35) 0.05 0.01 0.62 0.38
OAR16_37125504 16(34187287) 1.21E-03 −0.69(0.02) −0.38(0.23) 0.24 0.04 0.89 0.11
overall (weeks 1–23) OAR16_37125504 16(34187287) 1.08E-03 −0.22(0.26) 0.12(0.56) 0.04 0.01 0.89 0.11
oar3_OAR19_27,100,147 19(27100147) 1.09E-03 0.36(0.03) 0.42(0.01) 0.51 0.02 0.85 0.15
oar3_OAR19_27,830,713 19(27830713) 1.16E-03 −0.18(0.00) 0.09(0.21) 0.07 0.01 0.62 0.38
oar3_OAR19_27,830,713 19(27830713) 8.81E-04 −0.27(0.00) 0.08(0.37) 0.2 0.04 0.62 0.38
TVC early (weeks 1–7) OAR2_219801849 2(207575434) 5.81E-09 0.27(0.00) −0.23(0.03) 0.33 0.02 0.25 0.75
late (weeks 18–23) OAR2_219838408_X 2(207609417) 1.49E-08 0.22(0.03) −0.17(0.11) 0.22 0.02 0.26 0.74
OAR2_219641896 2(207420807) 1.26E-06 −0.15(0.27) −0.08(0.59) 0.07 0.01 0.83 0.17
oar3_OAR2_209,240,636 2(209240636) 2.85E-06 −0.19(0.51) −0.32(0.09) 0.05 0 0.93 0.07
oar3_OAR2_208,650,955 2(208650955) 2.26E-05 −0.12(0.18) −0.32(0.00) 0.07 0 0.71 0.29
oar3_OAR2_206,805,418 2(206805418) 4.11E-04 −0.15(0.00) 0.28(0.19) 0.03 0 0.99 0.01
OAR2_220844191 2(208597501) 4.81E-04 −0.10(0.22) −0.16(0.10) 0.05 0 0.69 0.31
Banos et al. BMC Genomics  (2017) 18:624 Page 5 of 18
Among all the genes located in the candidate regions
for mastitis resistance identified in the present study,
several (DAB2, IDH1, NDUFS1, MRPL42, FYB, SOCS2,
OSMR, RGMB, PPP4R2, EGFLAM and NUDT4) were
highly expressed in both mammary gland and various
immune cell lines as shown in Additional file 11: Figure S4.
These genes, along with others (CTLA4, CCNYL1, CEP83,
CHD1, TTC33, METTL21A, PLXNC1, CARD6, FASTKD2,
PRKAA1 and PTGER4) were also inducible by LPS in sheep
BMDMs (Fig. 4a and b).
Moreover, the expression of CCNYL1, IDH1, SOCS2,
MRPL42, C9, NDUFS1 and NUDT4 was relatively higher
than other genes in the milk transcriptome (Additional
file 12: Figure S5). Some of the LPS-inducible genes
(SOCS2, CARD6, C9, METTL21A and TTC33) were
differentially expressed in the milk somatic cells of sheep
Table 3 List of SNPs associated with clinical mastitis occurrence and three mastitis indicator traits in Chios sheep (Continued)
oar3_OAR2_206,036,682 2(206036682) 1.24E-03 −0.49(0.00) −0.50(0.00) 0.12 0.01 0.84 0.16
overall (weeks 1–23) OAR16_38842323 16(35633299) 1.27E-03 0.05(0.00) −0.01(0.84) 0.06 0 0.8 0.2
OAR16_37125504 16(34187287) 1.32E-03 −0.30(0.01) −0.13(0.29) 0.15 0.01 0.89 0.11
OAR19_27896777 19(26442150) 9.83E-04 0.16(0.16) −0.03(0.79) 0.07 0 0.91 0.09
CM OAR16_39143709 16(35930429) 6.98E-06 −1.72(0.36) 0.41(0.52) 0.25 0.05 0.54 0.46
early (weeks 1–7) OAR16_37226202 16(34279856) 4.16E-04 2.04(0.02) −0.80(0.39) 0.28 0.05 0.51 0.49
s74559 16(35801129) 4.41E-04 3.50(0.53) 2.81(0.61) 0.33 0.02 0.58 0.42
OAR16_37419505 16(34392335) 1.21E-03 −3.27(0.06) 1.74(0.16) 0.19 0.05 0.62 0.38
OAR16_37539041 16(34550197) 1.76E-03 1.60(0.01) −1.17(0.13) 0.26 0.05 0.39 0.61
oar3_OAR19_28,110,151 19(28110151) 6.23E-06 0.98(0.04) 0.74(0.12) 0.25 0.05 0.86 0.14
OAR19_29776311 19(28134366) 5.92E-05 1.02(0.05) 0.88(0.13) 0.25 0.04 0.87 0.13
OAR19_29193780 19(27558690) 4.95E-04 3.02(0.76) 2.66(0.79) 0.21 0.04 0.75 0.25
oar3_OAR19_27,018,360 19(27018360) 8.26E-04 −1.11(0.05) 0.95(0.12) 0.26 0.05 0.46 0.54
OAR5_104431404 5(95881956) 1.18E-06 0.82(0.00) 0.29(0.39) 0.35 0.06 0.6 0.4
mid (weeks 8–17) oar3_OAR5_96,114,753 5(96114753) 8.66E-06 0.87(0.00) 0.41(0.25) 0.39 0.07 0.59 0.41
OAR5_104389335_X 5(95841910) 2.28E-05 1.02(0.02) −1.01(0.06) 0.27 0.09 0.64 0.36
oar3_OAR5_96,077,046 5(96077046) 1.08E-04 0.59(0.03) 0.89(0.05) 0.12 0.03 0.41 0.59
oar3_OAR5_96,062,963 5(96062963) 1.07E-03 0.44(0.07) −0.22(0.14) 0.12 0.02 0.43 0.57
OAR16_37226202 16(34279856) 1.26E-03 2.02(0.02) 1.27(0.03) 0.21 0.04 0.51 0.49
OAR16_37539041 16(34550197) 1.94E-03 1.60(0.01) −1.17(0.13) 0.26 0.05 0.39 0.61
oar3_OAR19_26,565,985 19(26565985) 5.65E-04 −0.70(0.04) 0.32(0.48) 0.25 0.05 0.52 0.48
oar3_OAR19_26808003 19(268,080,030 6.95E-04 −0.58(0.05) −0.07(0.97) 0.14 0.02 0.74 0.26
OAR19_29482474 19(27864985) 1.30E-03 −3.49(0.86) −3.33(0.87) 0.23 0.04 0.1 0.9
late (weeks 18–23) oar3_OAR5_96,114,753 5(96114753) 1.81E-03 1.00(0.03) 0.81(0.10) 0.42 0.08 0.59 0.41
OAR5_104431404 5(95881956) 2.89E-04 0.98(0.03) 0.71(0.15) 0.4 0.07 0.6 0.4
OAR5_104389335_X 5(95841910) 9.99E-04 0.47(0.04) 0.66(0.17) 0.21 0.02 0.64 0.36
oar3_OAR5_96,114,753 5(96114753) 1.14E-03 0.62(0.01) 0.32(0.25) 0.24 0.04 0.59 0.41
OAR19_29776311 19(28134366) 1.08E-03 1.08(0.00) 1.07(0.01) 0.28 0.05 0.87 0.13
oar3_OAR19_27,264,253 19(27264253) 1.31E-03 1.00(0.03) 0.23(0.64) 0.42 0.08 0.59 0.41
oar3_OAR19_28,110,151 19(28110151) 1.53E-04 0.98(0.05) 0.74(0.21) 0.25 0.05 0.86 0.14
oar3_OAR19_26,565,985 19(26565985) 5.21E-04 −0.42(0.06) −0.06(0.82) 0.1 0.02 0.52 0.48
OAR19_29193780 19(27558690) 1.35E-03 0.56(0.10) 0.08(0.82) 0.15 0.02 0.75 0.25
overall (weeks 1–23) oar3_OAR2_207,141,059 2(207141059) 1.25E-03 −0.24(0.00) −1.95(0.01) 0.1 0 0.96 0.04
oar3_OAR19_27,264,253 19(2726253) 1.35E-03 0.88(0.00) 0.11(0.71) 0.36 0.07 0.59 0.41
SCC log-transformed milk somatic cell counts; CMT California mastitis Test; TVC total viable bacterial count in milk; CM occurrence of clinical mastitis
aChr(position) is based on the Oar v3.1 assembly; GAS P–value: P-value from genomic association study (genome-wide significant in bold, suggestive significance
otherwise); a: additive allele substitution effect; d: dominance effect; PVA: proportion of the genetic variance explained by the SNP; PVP: proportion of the
phenotypic variance explained by the SNP; p and q allelic frequencies. No significant associations were identified for TVC and SCC in mid lactation
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with divergent levels of SCC (high, intermediate, low;
Fig. 5). Furthermore, the level of expression of OSMR,
METTL21A, CEP83, CHD1, PLXNC1, GPATCH2, ICOS,
PTGER4, CARD6 and LIFR were significantly associated
with SCC, but not with milk yield levels, in the Churra
and Assaf sheep.
Transcription factor binding site (TFBS) analysis
Selective breeding in dairy sheep has led to the develop-
ment of selective sweeps associated with milk produc-
tion traits that are common to different breeds [33]. The
apparent commonality of QTL regions affecting mastitis
amongst disparate dairy breeds suggest that they may
also share specific variants that confer this phenotype.
There are currently insufficient whole genome sequences
available to identify such variants on a population-wide
basis. Nevertheless, we examined the available genomes
of six meat sheep (Scottish Blackface x Texel; BFxT),
the cross used to create the transcriptomic atlas, and
six dairy sheep sequenced as part of the Sheep HapMap
project [15] (two of each Churra, Sakiz and Lacaune
breed). There is no publicly available Chios genome, but
the genetically similar East Aegean Sakiz breed [20] was
considered as a proxy in the present study. To focus
on likely functional elements, we identified candidate
TBFS within 1 kb of the annotated transcription start
site [34]. MATCH analysis [35] revealed similar TFBS
profiles between dairy and meat sheep in the majority
(62%) of the genes located in the candidate regions
for mastitis resistance. For the remaining genes, distinct
TFBS profiles may be attributed to differences among
individual animals rather than breed type (Additional
file 13: Table S8). Most of these latter genes (CHD1,
PRKAA1, TTC33, CARD6, DAB2, FYB, OSMR, PPP4R2,
C6, C9, PTGER4 and LIFR) were also differentially
expressed in BMDMs after LPS treatment and/or in sheep
with differing SCC. In general, no systematic differences
were observed in TFBS profiles between dairy and meat
sheep except for the following: (1) Mat1-Mc and AP-1
binding sites upstream of the OSMR and PDZRN3 genes,
respectively, only in dairy sheep; (2) an HNF-1 binding
site upstream of DAB2, only in meat sheep; and (3)
HSF and c-Rel sites upstream of C9, only in meat and
dairy sheep, respectively.
Selection of candidate genes
Based on all above results, a total of 14 genes were selected
as the most promising candidate genes for mastitis resist-
ance (Table 4) in the present study. Genes were selected
using a combination of their known biological function, in-
volvement in immune response pathways and networks,
differential expression or enrichment in tissues relevant to
mastitis, differences in TFBS, association of their expression
levels with SCC and/or any previously known association
with mastitis resistance in either dairy sheep or dairy cattle.
Discussion
The present study investigated the genomic architecture
of mastitis resistance in Chios dairy sheep and assessed
the utility of relevant genomic data in genetic improve-
ment. Five QTLs located on chromosomes 2, 3, 5, 16 and
19 that had been previously identified in three unrelated
dairy sheep populations in France, Spain and Italy were
found to be segregating in an independent Greek sheep
breed, suggesting that genetic variation may persist in
diverse populations and that joint genomic selection pro-
grammes for enhanced mastitis resistance across breeds
are, in principle, feasible. The high proportion of genetic
variance explained by the five common QTL regions
renders this mastitis-specific 960SNP-array a useful tool
in dairy sheep breeding and genetic improvement.
The significance of the QTL regions reported in the
present study is supported by results of a previous selec-
tion mapping study that compared dairy with meat
sheep breeds to identify genomic regions under selection
[33]. In the latter study, multiple pairs of dairy versus
meat sheep breeds were investigated. For two specific
pairs a selection signal was identified in the QTL region
for mastitis resistance on chromosome 16 reported in
the present study; for another pair, a selection signal was
also identified close to our QTL regions on chromo-
somes 2, 3 and 19. The consistency of these selective
sweep signals with the QTLs verified in the present
study attest to the significance and suitability of the gen-
omic regions included in the custom-made 960SNP
array for dairy sheep populations.
Substantial genetic variance was detected in all mastitis
traits of our study. Nevertheless, our findings corroborate
the notion that mastitis resistance is under mostly poly-
genic genetic control [7, 16, 36], since 60–70% of the
(See figure on previous page.)
Fig. 2 Manhattan plots displaying the genomic association results of the mastitis traits studied in Chios sheep. Manhattan plots for milk somatic
cell count (SCC) in early (a), late (b), and overall (c) lactation; for California mastitis test (CMT) in early (d), mid (e), late (f), and overall (g) lactation;
for total viable bacterial count in milk (TVC) in early (h), late (i), and overall (j) lactation; for clinical mastitis occurrence (CM) in early (k), mid (l),
late (m), and overall (n) lactation. Chromosome location is plotted against -log10(P). Red and blue lines, respectively, are thresholds for significance
post-Bonferroni correction (P < 0.05) and for suggestive significance (accounting for one false positive per genome scan). No significant results
were identified for TVC and SCC in mid lactation
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genetic variance remained unexplained by the identified
QTLs. Previous genetic studies on other breeds, reviewed
by Bishop et al. [2], reported similar heritabilities ranging
from 0.10 to 0.20 for SCC. Significant positive phenotypic
and genetic correlations were detected between the CM
occurrence and the three mastitis indicator traits (SCC,
CMT and TVC) implying some common underlying
mechanisms of resistance between acute clinical episodes
and persistent intra-mammary inflammations. Similar cor-
relations between CM and SCC have been reported in the
Lacaune dairy sheep [32, 37] and cattle [38]. These results
confirm the utility of the indirect mastitis measures as pre-
dictors of CM in genetic improvement programmes as well
as on-farm management practices. Furthermore, the three
mastitis indicator traits in the present study appeared to be
under generally similar genetic mechanisms of control.
Considering that the average incidence of clinical mastitis
in a well-managed flock is about 2–3% and the incidence of
subclinical mastitis is much higher, the use of indicator
traits associated with the latter would facilitate breeding
programmes achieving improvements in both subclinical
and clinical mastitis resistance. CMT and TVC were stud-
ied for the first time as phenotypes for breeding purposes.
Implementation of CMT would constitute a useful tool to
phenotype mastitis resistance on the farm without requiring
any special equipment.
In Lacaune sheep, a previous transcriptomic study of
SCC associated 7 genes – cytotoxic T lymphocyte-
associated protein 4 (CTLA4), suppressor of cytokine
signalling 2 (SOCS2), oncostatin M receptor (OSMR),
FYN oncogene related to SRC (FYN), complement factor
B (CFB) and isocitrate dehydrogenase 2 (NADP+), soluble
(IDH2) – with mastitis susceptibility [32]. In the present
study, several of these genes (CTLA4, SOCS2, OSMR),
along with some from the same family (FYB, C9, IDH1),
were also found to be LPS-inducible in BFxT sheep
BMDMs and/or differentially expressed in the milk som-
atic cells of Churra and Assaf, indicating they are likely to
be involved in protective immunity across sheep popula-
tions. The SNP marker located within the IDH1 gene
Fig. 3 Pathway and network analysis using the IPA software. a The
most highly represented canonical pathways derived from genes
located within the candidate regions for mastitis resistance in Chios
sheep. The solid yellow line represents the significance threshold.
The line joining squares represents the ratio of the genes represented
within each pathway to the total number of genes in the pathway. b
Two networks, both related to immunological disease, that illustrate
the molecular interactions between the products of candidate genes
selected from QTL regions for mastitis resistance in Chios sheep.
Arrows with solid lines represent direct interactions and arrows with
broken lines represent indirect interactions. Genes with white labels are
those added to the IPA analysis because of their interaction with the
target gene products
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corresponds to a missense mutation but further work is
needed to verify if this is the actual causative mutation.
For the OSMR and C9 genes, differences in the TFBS in
the 1 kb upstream regions were also identified among
dairy and meat sheep. The proto-oncogene c-Rel – whose
binding site was identified in the sequence upstream of C9
in dairy sheep – is a member of the nuclear factor
kappa b (NFkb) family of transcription factors, whose
activity has been previously related with mastitis resist-
ance in dairy cattle [39]. However, further studies are
needed to confirm if these promoter variants are
functionally important. Moreover, most of the candidate
genes for mastitis resistance identified in the present study
were previously reported to control mastitis resistance in
dairy cattle, including CTLA4 [40], IDH1, OSMR, C6, C7
and C9, mitogen-responsive phosphoprotein, homolog
2 (DAB2), caspase recruitment domain family, member
6 (CARD6) [41, 42], and prostaglandin E receptor 4
(PTGER4) [43, 44]. This suggests that dairy sheep and
cattle may partially share common underlying mecha-
nisms and genes critical to a successful host response to
mastitis infection.
Fig. 4 Differential expression of genes located in the candidate regions for mastitis resistance post treatment with LPS. Each column represents
gene expression level in sheep bone marrow-derived macrophages 0, 2, 4, 7 and 24 h post treatment with LPS, respectively. Expression level is
shown as (a) average TPM (transcripts per million) at the 5 different time points, and (b) as log2 fold change in expression at 2, 4, 7 and 24 h
relative to expression at 0 h. Significance thresholds indicated as: P < 0.05*, P < 0.01** and P < 0.001***
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Based upon their transcriptional profiles and association
with SCC, novel functional candidates for mastitis resist-
ance were identified in the present study. These include
inducible T-cell co-stimulator (ICOS), leukaemia inhibi-
tory factor receptor A (LIFR), plexin C1 (PLXNC1) and
chromodomain-helicase-DNA-binding protein 1 (CHD1).
The proteins encoded by these genes have been previously
associated with multiple diseases in humans [45–49] and
other species [50]. The clear enrichment of LPS-inducible
genes in the QTL regions also offers the possibility of
using this assay to identify both cis- and trans-acting
eQTLs that are relevant to mastitis, similar to a previous
study of human monocytes that highlighted loci associated
with inflammatory disease susceptibility [22]. The fact that
the set of LPS-inducible genes overlaps with genes whose
level of expression was correlated with SCC attests to the
utility of the assay as a model for mastitis in sheep.
However, further studies are needed to confirm the
present results and identify the actual causative genes
and mutations.
Conclusion
Both innate and adaptive immune responses, along with
the induction of specific metabolic genes, are likely to be
involved in the genomic architecture of sheep resistance
to mastitis. All the mastitis traits analysed in the present
study exhibited heritable variation, suggesting that selec-
tion and management programmes aiming at enhancing
mastitis resistance are feasible. Genetic selection against
mastitis may be achieved using primarily indirect (indica-
tor) traits such as SCC, CMT and TVC but a combination
of both clinical mastitis and indicator traits would be pref-
erable. A possible implementation scenario might entail
marker-assisted selection based on validated selectable
markers and the candidate genes identified in the present
study. Another option would be the implementation of
genomic prediction and selection schemes across different
dairy sheep breeds sharing common QTLs for mastitis
resistance, leading to enhanced reference population size
and greater accuracy.
Methods
Ethics statement
The study was approved by the Ethics and Research
Committee of the Faculty of Veterinary Medicine, Aristotle
University of Thessaloniki, Greece. Permits for access and
use of the commercial farms were granted by the individual
farm owners, who were members of the Chios Sheep
Breeders’ Cooperative “Macedonia”. During sampling, ani-
mals were handled by qualified veterinarians. Permission to
qualified veterinarians to perform milk and blood sampling
was granted by the National (Greek) Legislature for the
Veterinary Profession, No. 344/29–12-2000. For the ovine
transcriptional atlas study approval was obtained from The
Roslin Institute’s and the University of Edinburgh’s Protocols
and Ethics Committees. All animal work was carried out
under the regulations of the Animals (Scientific Procedures)
Act 1986.
Principal component analysis
A total of 23 Chios, 103 Lacaune, 120 Churra and 20
Sarda dairy sheep were analysed within the sheep HapMap
project [15]. Genotyping and SNP quality control are
detailed in Kijas et al. [20]. PCA was performed using
PLINK v1.9 [51], which created an identity-by-state matrix
for assessing the genetic differences among the four popu-
lations, and allowed the average genetic distance between
Chios and each of the other three breeds to be estimated.
Fig. 5 Differential expression of genes located in the candidate regions for mastitis resistance across individuals with low, medium and high milk
somatic cell count. Expression in milk somatic cells is shown as average TPM (transcripts per million) across all experimental replicates. Significance
values were estimated using Tukey’s HSD post hoc test (P < 0.05*)
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Animals, sampling and phenotyping
A total of 609 purebred Chios dairy ewes in the first or
second lactation, raised in four commercial farms in
Greece, were used. Presence or absence (0/1) of CM was
recorded by an experienced veterinarian in monthly
visits during the first five months of lactation. On the
day of visit, two 50 ml milk samples were collected in
the milking parlour under aseptic conditions for the
measurement of three traits indirectly related with mas-
titis: CMT, SCC and TVC. CMT was scored on a scale
from 0 to 4 [52], with high values indicating the presence of
elevated SCC and, potentially, pathogens in milk; this test
was performed with a commercial kit according to manu-
facturer’s instructions (Bovi-vet, Kruuse, Germany). SCC
was measured with Fossomatic 360 (Foss Electric, Hillerød,
Denmark) and expressed as the number of cells/ml of milk.
TVC was measured with Bactoscan FC 50 (Foss Electric,
Hillerød, Denmark) and expressed as the number of viable
bacteria/ml of milk. In total, 2436 individual animal records
were collected. Peripheral blood samples were collected
from each ewe in 9 ml K2EDTAVacutainer blood collection
tubes (BD diagnostics) by jugular venepuncture for
genomic DNA extraction.
A total of 638 samples with a CMT score greater than
or equal to 2 and/or at least 500,000 somatic cells/ml
milk (cut-off values selected on the basis of bibliographic
evidence [53]), were further tested by selective culturing
on MacConkey agar for Gram-negative bacteria, and on
Mannitol Salt agar and Blood agar followed by Gram
staining for Gram positive bacteria. The plates were
incubated at approximately 37 °C for 24 h. The next day,
the plates were examined for bacterial growth.
Genetic parameter estimation
The distributions of SCC and TVC records were skewed;
therefore, records were naturally log-transformed in order
to achieve normality of the respective distributions.
Monthly animal records were analysed with the following
mixed model to derive variance components and genetic
parameters for the overall lactation; each trait was ana-
lysed separately:
Y ijkmno ¼ μþ Fi þ YSj þ a1  ageþ Lk
þ
X2
n¼1 bnPnWm þ go þ peo þ eijkmno ð1Þ
Where: Y = record of ewe o in week of lactation (i.e.
week post-lambing) m
μ = overall mean
F = fixed effect of flock i
YS = fixed effect of year-season of lambing j
α1 = linear regression on age at lambing (age)
L = fixed effect of lactation number k
W = fixed effect of week of lactation m
bn = fixed regression coefficient on week of lactation
m (order n = 2)
Pn = orthogonal polynomial of week of lactation m
(order n = 2)
g = random additive genetic effect of ewe o, including
pedigree genetic relationships among animals
pe = random permanent environment effect of ewe o
e = random residual effect
A Logit function was fitted to the CM analysis to account
for the binary nature (0/1) of the trait. For all traits, the
fixed regression on week of lactation yielded a smoothed
curve illustrating the trait progression throughout lactation.
Heritability and repeatability estimates were derived from
the variance components of the random effects for each
trait. Residuals from these analyses were kept to be used as
dependent variables in the ensuing genomic association
studies aiming to assess the effect of SNPs on the respective
traits expressed across the entire lactation. Subsequently,
bivariate analyses were conducted with the above model to
estimate genetic and phenotypic correlations among traits.
In separate analyses of SCC, CMT and TVC, second-
order polynomial functions of week of lactation were fitted
to the additive genetic and permanent environment effects
of model (1), resulting in separate variance component and
genetic parameter estimates by week of lactation. The latter
were then combined to derive average heritability and re-
peatability estimates for early (weeks of lactation 1–7), mid
(weeks 8–17) and late (weeks 18–23) lactation. The corre-
sponding residuals were also kept as input variables to the
genomic association studies aiming to assess the impact of
SNPs on traits expressed in different stages of lactation.
These analyses were not possible with the Logit function
fitted to the analysis of binary CM. Therefore, a linear
model was fitted to this trait in order to derive residuals
by lactation stage for the genomic association analysis.
All mixed model analyses were conducted with ASReml
v4.0 [54].
DNA extraction
Genomic DNA for all samples was extracted from blood
buffy coat using a modified protocol (Modified Blood) as
described by Psifidi et al. [55].
Genomic association analysis
All animals were genotyped with a customized 960-SNP
DNA array containing SNPs located in seven previously
identified QTL regions for mastitis resistance on chro-
mosomes 2, 3, 5, 12, 16 and 19. Details of the SNPs
comprising the DNA array are presented in Additional
file 14: Table S9. SNP genotypes were subjected to quality
control measures using the following thresholds: minor al-
lele frequency < 0.05, call rate < 95% and Hardy-Weinberg
equilibrium P < 10−6. After quality control, 710 SNP
markers remained for further analysis. SNP locations were
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obtained from the Oar v3.1 assembly using the Ensembl
genome browser (www.ensembl.org). To account for
possible population stratification, a genomic relation-
ship matrix was generated including all individual
animals. This genomic relationship matrix was converted
to a distance matrix that was used to carry out classical
MDS analysis with the R package GenABEL [56]. Individual
ewe phenotypes were adjusted for the same fixed effects
included in model (1). Phenotypes pertained to the entire
course of lactation as well as to different stages (early, mid,
late) of lactation as explained above. In all cases, GEMMA
v0.94.1 [57] was used to run the genomic association
analyses of adjusted phenotypes based on a mixed model
that included the genomic relationship matrix among indi-
vidual ewes as a random effect. After Bonferroni correction
for multiple testing, the P ≤ 0.05 significance threshold was
set at P ≤ 7.04 × 10−5 and a suggestive significance thresh-
old (accounting for one false positive per genome scan) was
set at P ≤ 1.41 × 10−3.
LD among significant SNPs was calculated as an r2
value using PLINK v1.9 [51] in order to evaluate the
extent of LD and identify candidate regions potentially
containing causal mutations for mastitis resistance. Fur-
thermore, LD blocks in the regions where significant
SNPs were found with GWAS were visualised using the
software Haploview v4.2 [58]
SNP locus effect confirmation
Individual markers found to be significant in the previous
step were further examined with a mixed model that
included the fixed effects of model (1), the fixed effect of
the corresponding SNP locus genotype and the random
effect of the animal. Additive (a) and dominance (d) ef-
fects, and the proportion of additive genetic variance
(PVA) and total phenotypic variance (PVP) due to each
SNP locus were calculated as follows:
a ¼ AA−BBð Þ=2
d ¼ AB− AAþ BBð Þ=2ð Þ
PVA ¼ 2pq aþ d q−pð Þð Þ2
 
=VA
PVP ¼ 2pq aþ d q−pð Þð Þ2
 
=VP
where AA, BB and AB were the predicted trait values of
the respective genotypic classes, p and q were the allelic
frequencies of A and B at the SNP locus, and VA and
VP were the additive genetic and total phenotypic variance
of the trait. The latter were estimated with model (1). All
analyses were run with ASReml v4.0 [54].
Annotation of the SNP markers and the QTL candidate
regions
For sheep assembly Oar v3.1, the Ensembl Variant Effect
Predictor (VEP) (http://www.ensembl.org/Tools/VEP) and
BioMart data mining tools (http://www.ensembl.org/bio
mart/martview/) were used to map and annotate the sig-
nificant SNP markers derived with the genomic association
analysis on the reference genome, and to locate genes in
the corresponding candidate regions for mastitis resistance.
Pathway and functional annotation clustering analysis
Gene lists in the candidate regions for mastitis resistance
were analysed using the Ingenuity Pathway Analysis (IPA)
programme (www.ingenuity.com) in order to identify
canonical pathways and gene networks constructed by the
products of these genes. IPA constructs multiple possible
upstream regulators, pathways and networks serving as
hypotheses for the biological mechanism underlying the
trait. This analysis uses data from a large-scale causal
network derived from the Ingenuity Knowledge Base. IPA
then infers the most suitable pathways and networks
based on their statistical significance, thereby setting a
threshold above which the pathways are significant.
Gene lists were also analysed against an Ovis aries back-
ground using the Database for Annotation, Visualization
and Integrated Discovery (DAVID v6.7) [59]. For each
gene, we determined its GO terms and performed func-
tional annotation clustering analysis to detect possible
enrichment. The ES calculated with DAVID is a modified
Fisher’s exact test P-value, with increasing ES (>1) reflect-
ing over-representation of that functional category.
Gene expression analysis
Expression levels of each gene located within candidate
regions for a mastitis trait were obtained from a tran-
scriptomic atlas of 406 RNA-seq libraries, representing
all major organ systems; the atlas was based on a BFxT
sheep cross [23] and also included 83 libraries from a
Texel sheep trio (ewe, ram and lamb) as described in
Jiang et al. [60]. In the present study, we were specifically
interested in mammary gland, immune-related tissues and
cell lines. Therefore, we extracted data pertaining to the
haemolymph nodes, mesenteric, popliteal, prescapular
and submandibular lymph nodes, peripheral blood mono-
nuclear cells, blood leukocytes, monocyte-derived macro-
phages, alveolar macrophages, tonsils, and mammary
glands. The atlas also contained data from sheep BMDMs
at different time points (0 h, 2 h, 4 h, 7 h and 24 h) after
LPS treatment [23], which we used here as a model for
mastitis, to identify candidate genes that are likely in-
volved in the inflammatory response to bacterial infection.
LPS stimulation mimics Gram-negative pathogens, which
accounted for 12% of the mastitis incidence in the Chios
sheep in the present study. LPS stimulation also provides
a general model for toll-like receptor (TLR) signalling and
inflammatory pathology which causes morbidity and pro-
duction losses associated with mastitis. To supplement
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this dataset, we obtained expression levels from a previous
transcriptomic study of the milk somatic cells of two
Spanish dairy sheep breeds, Churra and Assaf [27]. The
sheep used in this study had also been phenotyped for
SCC and milk yield [26]; these records were made avail-
able to the present study.
To generate RNA for library preparation, BMDMs
were differentiated for 7 days in recombinant human
colony stimulating factor and treated with LPS (Salmonella
minnesota Re 595 (L9764; Sigma-Aldrich)) at a concentra-
tion of 100 ng/ml. Salmonella is a TLR4 agonist; Staphylo-
coccus aureus, which is the main cause of mastitis in dairy
sheep, is known to activate both TLR2 and TLR4 [61] in
cattle. BMDMs were harvested into Trizol (Thermofisher)
at each different time point post LPS treatment in prepar-
ation for RNA extraction. For all samples in the transcrip-
tomic atlas, RNA was extracted using Trizol (Thermofisher)
followed by column purification and DNAse treatment
using the RNeasy Mini Kit (Qiagen). The resultant RNA
was checked for quality using the Agilent Tapestation
2200, and all samples were of high quality with RNA
Integrity Numbers (RINe) greater than 9. All RNA-Seq
libraries from the sheep transcriptional atlas included in
this study were TruSeq stranded mRNA libraries (125 bp
paired-end). Libraries were prepared by Edinburgh Gen-
omics (https://genomics.ed.ac.uk/) using the TruSeq mRNA
Library Preparation kit (Illumina) and sequenced on the
Illumina HiSeq v2500 at a depth of >25 million reads
per sample.
Expression levels for all samples from both the tran-
scriptomic atlas and the milk somatic cell transcriptome
were estimated using Kallisto v0.42.4 [62]. Rather than
aligning RNA-seq reads to a reference genome, recon-
structing transcripts from these alignments and then
quantifying expression as a function of the reads aligned
(the conventional means of RNA-seq processing), Kallisto
employs a ‘lightweight’ algorithm, which first builds an
index of k-mers from a known transcriptome: the Ovis aries
v3.1 cDNAs (ftp://ftp.ensembl.org/pub/release-83/fasta/
ovis_aries/cdna/Ovis_aries.Oar_v3.1.cdna.all.fa.gz, ob-
tained from Ensembl v84 [63]; n = 23,113 transcripts
[22,823 protein-coding, 247 pseudogenes, 43 processed
pseudogenes]). Expression level is then estimated dir-
ectly (i.e., in an alignment-free manner) by quantifying
exact matches between reads and k-mers. Expression is
reported per transcript as the number of transcripts per
million, and is summarised to the gene-level as de-
scribed previously [64].
Differential expression analysis was run on the LPS time
series data using the Kallisto output with the R/Biocon-
ductor package ‘Sleuth’. Heatmaps were drawn using the
heatmap.2 function from the R package gplots v3.0.1.
Additional differential expression analyses were conducted
between sheep with high, moderate and low levels of SCC,
after adjusting for breed (Churra and Assaf). Relevant data
for this study are described by Suarez-Vega et al. [22].
Least square mean pairwise comparisons between SCC
levels were conducted. Tukey’s HSD post-hoc test adjust-
ment was applied at a significance level of 0.05.
Furthermore, the effect of the expression level of each
gene (located within a candidate region for mastitis
resistance) on SCC and milk yield was assessed using
the following linear model:
Yij ¼ μþ Bi þ gj þ eij ð2Þ
where Y = record of ewe (SCC or milk yield across lacta-
tion), μ = overall mean, B = fixed effect of breed i, g = fixed
effect of the mean expression of gene j, e = random residual
effect.
The significance threshold in this analysis was set at
0.05. Since genes were located within 5 QTL regions, an
FDR adjustment for multiple testing was applied and the
significance threshold was subsequently re-set to
P ≤ 0.0125. The analyses were conducted with ASReml
v4.0 [36].
Transcription factor binding site analysis
In order to identify whether differences in TFBS are as-
sociated with differences in expression level of the genes
found in the candidate regions for mastitis resistance,
we extracted and compared the corresponding 1 kb up-
stream sequence in all genes from both meat and dairy
sheep. Specifically, we extracted the sequences from the
six sheep used to create the BFxT transcriptomic atlas
and six sheep sequenced as part of the Sheep HapMap
Project [15] (two Churra, two Lacaune [one dairy and
one meat] and two Sakiz dairy sheep; NCBI Sequencing
Read Archive (SRA) accession numbers SRR501848,
SRR501909, SRR501850, SRR501851, SRR501843 and
SRR501878, respectively; BioProject PRJNA160933).
The six atlas sheep (BFxT) had been fully re-sequenced.
Illumina Tru-Seq Nano 350 gel-free libraries (125 bp
paired end) were prepared, for each sample, by Edinburgh
Genomics (https://genomics.ed.ac.uk). The six libraries
were run on one lane of the Illumina HiSeq2500 System
to generate in total approximately 220 M + 220 M reads
resulting in a 10-fold coverage per sample. Details of the
re-sequencing methodology within the HapMap sheep
project can be found in Kijas et al. [15]. In both cases,
the 1 kb upstream regions for each gene were extracted
using BEDTools v2.25 [65]. These were then analysed
using the MATCH algorithm within the TRANSFAC®
7.0 Suite, with default parameters, which predicts TFBS in
DNA sequences using a library of positional weight
matrices [35].
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measures in different lactation stages in Chios sheep. (DOCX 12 kb)
Additional file 5: Figure S2. Q-Q plots displaying the genomic association
results for the mastitis traits studied in Chios sheep. Q-Q plots for milk somatic
cell count (SCC) in early (A), late (B) and overall (C) lactation; for
California mastitis test (CMT) in early (D), mid (E), late (F) and overall
(G) lactation; for total viable bacterial count in milk (TVC) in early (H),
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are plotted against the expected P-values for each trait. Q-Q plots are
not presented for TVC and SCC in mid lactation since no significant
results for these traits were identified. (DOCX 248 kb)
Additional file 6: Table S4. Linkage disequilibrium (LD) estimation
(as r2) for the significant SNP markers identified in the genomic
association analyses of mastitis resistance in Chios sheep. (XLSX 13 kb)
Additional file 7: Figure S3. Patterns of linkage disequilibrium (LD) for
SNP markers associated significantly with mastitis resistance in Chios
sheep. LD patterns are shown for chromosomes 2 (A), 3 (B), 5 (C), 16 (D)
and 19 (E). LD blocks are marked with triangles. The significant markers
are illustrated with a blue arrow. The candidate regions for mastitis
resistance identified in previous studies and in Chios sheep (present
study) are marked with dashed lines. The strongest LD signals are in red
and the weakest in white. (DOCX 1060 kb)
Additional file 8: Table S5. Genes located in the candidate genomic
regions for mastitis resistance in Chios sheep. (XLSX 15 kb)
Additional file 9: Table S6. Annotation of SNPs identified to have a
significant association with mastitis resistance traits. (XLSX 16 kb)
Additional file 10: Table S7. Functional annotation clustering analysis
of the genes located in the candidate regions for mastitis resistance.
(XLSX 16 kb)
Additional file 11: Figure S4. Expression level of genes, located in the
mastitis resistance candidate regions, across both mammary glands and
immune cell lines/tissues. Expression level is estimated as the mean TPM
(transcripts per million) of all (5) experimental replicates and is represented
here as a Z-score per cell line/tissue. Data is obtained from two transcriptomic
atlases; one of Scottish Blackface x Texel (BFxT) sheep and one of Texel sheep.
(PNG 67 kb)
Additional file 12: Figure S5. Expression level of genes, located in the
mastitis resistance candidate regions, as extracted from the Churra/Assaf
milk somatic cell transcriptome analysis. Expression level is estimated as
the mean TPM (transcripts per million) of all (5) experimental replicates
and is represented here as a Z-score per individual animal. (PNG 54 kb)
Additional file 13: Table S8. Transcription factor binding site analysis
using the MATCH programme. (XLSX 41 kb)
Additional file 14: Table S9. List of SNP markers comprising the
mastitis-specific custom-made array used in the genomic association analysis
of Chios sheep. (XLSX 51 kb)
Additional file 15: Table S10. Expression levels of genes located in the
candidate regions for mastitis resistance identified in Chios sheep. The
gene expression levels presented here are across all the body tissues and
cell lines, as extracted from the two (BFxT and Texel) sheep transcriptomic
atlases. Details on the expression profile of each gene across the
transcriptomic atlas are also provided. (XLSX 71 kb)
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